| P50 | author | Ling-Sha Huang | Q91064877 |
| | Bo Zhu | Q91064879 |
| P2093 | author name string | Zhong-Qing Chen | |
| P2860 | cites work | Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes | Q28288181 |
| | Annual report on status of cancer in China, 2011 | Q35085507 |
| | The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma | Q36211371 |
| | A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer | Q36985025 |
| | The incidence and mortality of major cancers in China, 2012. | Q37148344 |
| | Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases | Q37213982 |
| | The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer | Q37315250 |
| | Estimates of cancer incidence and mortality in China, 2013 | Q38619604 |
| | Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis | Q38917304 |
| | The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 |
| | Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer. | Q40555102 |
| | Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma | Q41730209 |
| | Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis | Q41890324 |
| | Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix | Q43536959 |
| | Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer | Q44409626 |
| | Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples | Q47934167 |
| | Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. | Q48120088 |
| | Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site | Q48786351 |
| | Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations. | Q51063268 |
| | Assessment of Relationship Between CT Features and Serum Tumor Marker Index in Early-stage Lung Adenocarcinoma. | Q51635586 |
| | Lung adenocarcinoma with clear cell features producing carbohydrate antigen 19-9. | Q53023234 |
| | The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. | Q53229977 |
| | [A case of two patients with primary lung cancer secreting CA19-9] | Q69825019 |
| | Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types | Q70237988 |
| | Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer | Q72066829 |
| | A case of lung cancer producing CA19-9 and amylase | Q72084409 |
| | Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer | Q72386097 |
| | [CYFRA 21-1: initial experiences in bronchus carcinoma and other tumors] | Q72839142 |
| | Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer | Q73823235 |
| | [Tumor markers in lung cancer] | Q77489106 |
| | Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases | Q81712074 |
| | Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer | Q82664051 |
| | Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer | Q82791867 |
| | [Detecting MUC-1 mRNA for diagnosing peripheral blood micro-metastasis in non-small cell lung cancer patients] | Q82954359 |
| | CYFRA 21-1 as a tool for distant metastasis detection in lung cancer | Q83217672 |
| | Relationship between CT features and high preoperative serum carcinoembryonic antigen levels in early-stage lung adenocarcinoma | Q87435453 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 9845123 | |
| P577 | publication date | 2018-12-11 | |
| P1433 | published in | Disease Markers | Q15756044 |
| P1476 | title | Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer | |
| P478 | volume | 2018 | |